Coronavirus disease (COVID-19) technical guidance by WHO Infection prevention and control | Page 4

Infection prevention and control during health care when COVID-19 is suspected: interim guidance
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
World Health Organization. Infection prevention and
control during health care for probable or confirmed
cases of Middle East respiratory syndrome coronavirus
(MERS-CoV) infection: interim guidance (accessed
17 January 2020).
World Health Organization. Infection prevention and
control of epidemic- and pandemic-prone acute
respiratory diseases in health care. (accessed
17 January 2020).
World Health Organization. Guidelines on core
components of infection prevention and control
programmes at the national and acute health care
facility level. Geneva: World Health Organization;
2016 (accessed 20 January 2020).
Minimum requirements for infection prevention and
control. Geneva: World Health Organization; 2019
(https://www.who.int/infection-
prevention/publications/min-req-IPC-manual/en/,
accessed 20 January 2020).
WHO guidelines on hand hygiene in health care: first
global patient safety challenge – clean care is safer care.
Geneva: World Health Organization; 2009
(https://apps.who.int/iris/handle/10665/44102, accessed
17 January 2020).
How to put on and take off personal protective
equipment (PPE). Geneva: World Health Organization;
2008
(http://www.who.int/csr/resources/publications/putonta
keoffPPE/en/, accessed 17 January 2020).
Rational use of PPE
CDC and ICAN. Best Practices for Environmental
Cleaning in Healthcare Facilities in Resource-Limited
Settings. Atlanta, GA: US Department of Health and
Human Services, CDC; Cape Town, South Africa:
Infection Control Africa Network; 2019.
(https://www.cdc.gov/hai/prevent/resource-
limited/environmental-cleaning.html and
http://www.icanetwork.co.za/icanguideline2019/,
accessed 20 January 2020).
Decontamination and Reprocessing of Medical Devices
for Health-care Facilities. Geneva: World Health
Organization; 2016 (https://www.who.int/infection-
prevention/publications/decontamination/en/, accessed
20 January 2020).
Atkinson J, Chartier Y, Pessoa-Silva CK, Jensen P, Li
Y, Seto WH, editors. Natural ventilation for infection
control in health-care settings. Geneva: World Health
Organization; 2009
(https://apps.who.int/iris/handle/10665/44167, accessed
17 January 2020).
Hui DS. Epidemic and emerging coronaviruses (severe
acute respiratory syndrome and Middle East respiratory
syndrome). Clin Chest Med. 201738:71−86.
doi:10.1016/j.ccm.2016.11.007.
Tran K, Cimon K, Severn M, Pessoa-Silva CL, Conly J.
Aerosol generating procedures and risk of transmission
of acute respiratory infections to healthcare workers: a
systematic review. PLoS One. 2012;7:e35797. doi:
10.1371/journal.pone.0035797. Epub 2012 Apr 26.
How to perform a particulate respirator seal check.
Geneva: World Health Organization; 2008.
14.
15.
16.
17.
18.
(http://www.who.int/csr/resources/publications/respirat
orsealcheck/en/, accessed 17 January 2020). For the
latest information, please consult the WHO coronavirus
webpage
(http://www.who.int/csr/disease/coronavirus_infections/
en/).
Adams J, Bartram J, Chartier Y, editors. Essential
environmental health standards in health care. Geneva:
World Health Organization; 2008
(https://apps.who.int/iris/handle/10665/43767, accessed
17 January 2020).
Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-
Ansary LA, Bawazeer GA et al. Physical interventions
to interrupt or reduce the spread of respiratory viruses.
Cochrane Database Syst. Rev. 2011, 7:CD006207.
(http://onlinelibrary.wiley.com/doi/10.1002/14651858.
CD006207.pub4/abstract;jsessionid=074644E776469A
4CFB54F28D01B82835.d03t02. Accessed
17 January 2020).
Laboratory testing for 2019 novel coronavirus (2019-
nCoV) in suspected human cases: interim guidance
January 2020. Geneva: World Health Organization.
(https://apps.who.int/iris/bitstream/handle/10665/33067
6/9789240000971-eng.pdf).
Laboratory testing for Middle East respiratory syndrome
coronavirus: interim guidance (revised), January 2018.
Geneva:
World
Health
Organization;
2018
(https://apps.who.int/iris/bitstream/handle/10665/25995
2/WHO-MERS-LAB-15.1-Rev1-2018-
eng.pdf?sequence=1, accessed 17 January 2020).
Laboratory biosafety manual, third edition. Geneva:
World Health Organization; 2004
(https://apps.who.int/iris/handle/10665/42981, accessed
17 January 2020).
Acknowledgements
The original version of the MERS-CoV IPC guidance 1 was
developed in consultation with WHO’s Global Infection
Prevention and Control Network and Emerging Diseases
Clinical Assessment and Response Network, and other
international experts. WHO thanks those who were involved
in developing and updating the IPC documents.
This document was developed in consultation with the
WHO Global Infection Prevention and Control Network and
other international experts. WHO thanks the following for
their review (in alphabetical order):



- 4-
Abdullah M Assiri, Director General, Infection
Control, Ministry of Health, Saudi Arabia.
Michael Bell, Deputy Director of Division of
Healthcare Quality Promotion, Centers for Disease
Control and Prevention, Atlanta, USA.
Gail Carson, ISARIC Global Support Centre,
Director of Network Development, Consultant in
Infectious Diseases and Honorary Consultant
Public Health England, United Kingdom.